10
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Cerebrospinal Fluid Levels of IL-6 in Patients with Acute Infections of the Central Nervous System

, , , , , & show all
Pages 787-791 | Published online: 08 Jul 2009

References

  • Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11: 443–449
  • Le J, Vilcek J. Biology of disease. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588–602
  • Gauldie J, Richards C, Harnish D, Lansdorp P, Bauman H. Interferon beta2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84: 7251–7255
  • Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich P C. Induction of rat acutephase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18: 717–720
  • Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T. The essential role of B cell stimulatory factor (FSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167: 332–344
  • Houssiau F A, Bukasa K, Sindic C JM, VanDamme J, Van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 1988; 71: 320–323
  • Frei K, Leist T P, Meager A, Gallo P, Leppert D, Zinkernagel R M, Fontana A. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. J Exp Med 1988; 168: 449–453
  • Laurenzi M A, Siden A, Persson M AA, Norkrans G, Hagberg L, Chiodi F. Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin Immunol Immunopathol 1990; 57: 233–241
  • Ramilo O, Mustafa M M, Porter J, Saez-Llorens X, Mertsola J, Olsen K, Luby J P, Beutler B, McCracken G H. Detection of interleukin 1B but not tumor necrosis factor-a in cerebrospinal fluid of children with aseptic meningitis. Am J Dis Child 1990; 144: 349–352
  • Pierez-Victor L, Janssen R, Spira T, Fauci A S, Dubois R, Folks T. Presence of tumor necrosis factor in the CSF of AIDS patients with HIV encephalopathy. Fifth International Conference on AIDS. 1989; 4–9, Abstract WCP 87. Montreal (Canada)
  • Pfaller M A, Herwaldt L A. Laboratory, clinical and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1: 281–299
  • Torre D, Ferraro G, Fiori G P, Martegani R, Speranza F, Tambini R, Zeroli C. Ventriculo-atrial shunt infection caused by Staphylococcus warneri: case report and review of literature. Clin Infect Dis 1992; 14: 49–52
  • Nakajima K, Martinez-Maza O, Hirano T, Breen E C, Nishanian P G, Salazar-Gonzalez J F, Fahey J L, Kishimoto T. Induction of IL-6(B cell stimulatory factor-2/IFN-B2) production by HIV. J Immunol 1989; 142: 531–536
  • Helfgott D C, Tatter S B, Santhanam U, Clarick R H, Bhadwaj N, May L T, Sehgr P B. Multiple forms of IFN-B2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 1989; 142: 948–955
  • Mustafa M M, Lebel M H, Ramilo O, Olsen K D, Reisch J S, Beutler B, McCracken G H. Correlation of interleukin-lB and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989; 115: 208–213
  • Frei K, Fontana A. Immune regulatory functions of astrocytes and microglial cells within central nervous system. Neuroimmune networks: physiology and diseases, E J Goetzl, N H Spector. Alan R. Liss, New York 1989; 127–136
  • Rogers B C, Scott D M, Mundin J, Patrick-Sissons J G. Monocyte-derived inhibitor of interleukin-1 induced by human cytomegalovirus. J Virol 1985; 55: 527–532
  • Wainberg M A, Numazaki K, Destephano L, Wong I, Goldman H. Infection of human epithelial cells by human cytomegalovirus and other viruses: effect on secretion of interleukin 1-like activity. Clin Exp Immunol 1988; 72: 415–421

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.